ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 39911278

Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment.

Gudivada IP and 1 other. Curr Genomics, 2025. Cited by 100 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. Papers, record 39911278. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39911278

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment.
PubMed
Journal
Curr Genomics
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
100
iCite
Relative citation ratio, by iCite
28.6, provisional
iCite
Revised in PubMed
2025-02-07
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gudivada IPIndu Priya
2Amajala KCKrishna Chaitanya

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References109

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131,802,891NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling.Onco Targets Ther2019https://conductscience.org/library/papers/31802891PubMed
226,254,357Lack of Contribution of Multidrug Resistance-associated Protein and Organic Anion-transporting Polypeptide to Pharmacokinetics of Regorafenib, a Novel Multi-Kinase Inhibitor, in Rats.Anticancer Res2015https://conductscience.org/library/papers/26254357PubMed
330,593,276Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.Mol Cancer2018https://conductscience.org/library/papers/30593276PubMed
431,902,387Gene-environment interactions between HPA-axis genes and childhood maltreatment in depression: a systematic review.Acta Neuropsychiatr2020https://conductscience.org/library/papers/31902387PubMed
517,767,487Laser capture microdissection and microarray analysis of dividing neural progenitor cells from the adult rat hippocampus.Eur J Neurosci2007https://conductscience.org/library/papers/17767487PubMed
632,269,624BUB1 promotes proliferation of liver cancer cells by activating SMAD2 phosphorylation.Oncol Lett2020https://conductscience.org/library/papers/32269624PubMed
734,452,851EVenn: Easy to create repeatable and editable Venn diagrams and Venn networks online.J Genet Genomics2021https://conductscience.org/library/papers/34452851PubMed
835,082,522The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients.Int J Gen Med2022https://conductscience.org/library/papers/35082522PubMed
929,112,863The liver.Curr Biol2017https://conductscience.org/library/papers/29112863PubMed
1024,756,794Cabozantinib: a MET, RET, and VEGFR2 tyrosine kinase inhibitor.Recent Results Cancer Res2014https://conductscience.org/library/papers/24756794PubMed

1 to 10 of 109

See all 109 references

Cited by97

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.

PMIDTitleJournalYearIn PapersSource
42,984,553Nilotinib targets NEIL3-mediated fatty acid oxidation to promote anoikis in hepatocellular carcinoma cells.Front Oncol2026https://conductscience.org/library/papers/42984553PubMed
42,927,357Advances in the LI-RADS Treatment Response Algorithm: Imaging Principles, Diagnostic Challenges, and Clinical Integration Following the LI-RADS 2024 Update.Cancer Manag Res2026https://conductscience.org/library/papers/42927357PubMed
42,921,173
The Efficacy and Safety of Combined Locoregional and Systemic Therapy versus Systemic Therapy Alone in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis: A Multicenter Real-World Retrospective Cohort Study.
J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42921173PubMed
42,895,274Treatment patterns and outcomes in US patients with unresectable HCC treated with embolization.Hepat Oncol2026https://conductscience.org/library/papers/42895274PubMed
42,877,750Frailty After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Cross-Sectional Study of Incidence and Associated Factors.J Multidiscip Healthc2026https://conductscience.org/library/papers/42877750PubMed
42,866,008Palmatine Induces TNNT1 Ubiquitination and Degradation to Potentiate Ferroptosis Sensitivity in Hepatocellular Carcinoma.J Clin Transl Hepatol2026https://conductscience.org/library/papers/42866008PubMed
42,858,645A mature tertiary lymphoid structure-associated spatial niche is inversely associated with ACC1-related lipid metabolism in neoadjuvant-treated hepatocellular carcinoma.Transl Oncol2026https://conductscience.org/library/papers/42858645PubMed
42,830,978Hispidulin Suppresses Hepatocellular Carcinoma Proliferation by Targeting PI3K-Akt Pathway: A Network Pharmacology and Experimental Validation Study.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42830978PubMed
42,799,607Patient characteristics to guide personalized treatment decisions and prognostication in hepatocellular carcinoma.Hepat Oncol2026https://conductscience.org/library/papers/42799607PubMed
42,733,464Prediction of Post-Resection Prognosis of HCC According to AFP-PIVKA-II (AP) Score as a Simplified Biomarker of ADV Score: A Validation Analysis Using Korea Liver Cancer Registry Database.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42733464PubMed

1 to 10 of 97

See all 97 cited by

Genes21

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ASPM259,266PubTator's text mininghttps://conductscience.org/library/genes/259266NCBI Gene
BUB1699PubTator's text mininghttps://conductscience.org/library/genes/699NCBI Gene
BUB1B701PubTator's text mininghttps://conductscience.org/library/genes/701NCBI Gene
CCNA2890PubTator's text mininghttps://conductscience.org/library/genes/890NCBI Gene
CCNB29,133PubTator's text mininghttps://conductscience.org/library/genes/9133NCBI Gene
CDK1983PubTator's text mininghttps://conductscience.org/library/genes/983NCBI Gene
CENPF1,063PubTator's text mininghttps://conductscience.org/library/genes/1063NCBI Gene
CEP5555,165PubTator's text mininghttps://conductscience.org/library/genes/55165NCBI Gene
DLGAP59,787PubTator's text mininghttps://conductscience.org/library/genes/9787NCBI Gene
ELAVL21,993PubTator's text mininghttps://conductscience.org/library/genes/1993NCBI Gene

1 to 10 of 21

See all 21 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39911278

GET https://conductscience.org/api/papers/v1/39911278/references?page=2

API referenceFor AI assistants